Advertisement
+ News Categories + Corporate Categories + Report Categories

NEXT ARTICLE

FDA denies request to withdraw Avandia

11:04 EST 23 Nov 2011 | BioCentury

FDA rejected a Citizen's Petition from consumer advocacy group Public Citizen asking for withdrawal of diabetes drug Avandia rosiglitazone from the U.S. market. In September 2010, FDA significantly restricted Avandia's use based on cardiovascular saf..

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: FDA denies request to withdraw Avandia

BioCentury

 Channels 1 Associated Channels :: Search

  • The Top 100 Drugs

    The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Associated Content for this Article